India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its respiratory drugs and antibiotic Augmentin.

GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 ...

IND vs ENG 1st ODI Live: India win! An easy win this is for India as they win the first ODI by 4 wickets against England. Chasing 249, India reach home in 38.4 overs. The bowlers laid the platform ...

GlaxoSmithKline Pharmaceuticals Ltd reported an 18% revenue increase to ₹946 crore for Q3 ended December 31, 2024, with a ...

CEO Dame Emma Walmsley highlighted that GSK achieved 8% sales growth in 2024, reaching over £31 billion, with specialty medicines driving performance. Core operating profit grew 13%, supporting a ...

India Vs England 1st T20I highlights: Abhishek Sharma's scintillating 34-ball 79 helped India post a thumping win over England to go 1-0 up in the five-match T20I series on Wednesday in Kolkata.

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as investors ...

GlaxoSmithKline Pharma Ltd announced its Q3 results today posting a solid jump in its net profit. Consolidated PAT for the ...

Biopharmaceutical company GSK is growing its Massachusetts work force, announcing plans to move its vaccines research and development and infectious disease teams from suburban Maryland to ...

Like several other nations, India is working behind the scenes to appease the Trump administration and avoid the brunt of its trade threats. The crackdown on illegal migration has been a signature ...

India (133/3) defeated England (132 all out) by seven wickets in the first T20I of the five-match series in Kolkata. Chasing 133, India easily dominated the proceedings as their openers Sanju ...